beta-D-GalNAc-(1->4)-beta-D-GalNAc-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Man-(1->4)-beta-D-Glc-(1<->1')-Cer

Term ID

CHEBI:142443

Synonyms

(2S,3R,4E)-2-alkanamido-3-hydroxyoctadec-4-en-1-yl 2-acetamido-2-deoxy-alpha-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-beta-D-mannopyranosyl-(1->4)-beta-D-glucopyranoside
(2S,3R,4E)-2-alkanamido-3-hydroxyoctadec-4-en-1-yl N-acetyl-alpha-D-galactosaminyl-(1->4)-N-acetyl-beta-D-galactosaminyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-mannosyl-(1->4)-beta-D-glucoside
beta-D-GalpNAc-(1->4)-beta-D-GalpNAc-(1->4)-beta-D-GlcpNAc-(1->3)-beta-D-Manp-(1->4)-beta-D-Glcp-(1<->1')-Cer
GalNAcalpha4GalNAcbeta4GlcNAcbeta3Manbeta4Glcbeta1Cer
N5a

Definition

A sialotriaosylceramide consisting of a linear pentasaccharide made up from two N-acetylneuraminyl residues, an N-acetyl-beta-D-glucosaminyl residue, a mannosyl residue and a glucosyl residue at the reducing end attached to the ceramide portion via a beta-linkage.

References

PMID:7686134

Ontology

ChEBI ( EBI )

Relationships

is a type of: sialotriaosylceramide

sialotriaosylceramide Show first 5 Terms

Phenotype

Phenotype resulting from beta-D-GalNAc-(1->4)-beta-D-GalNAc-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Man-(1->4)-beta-D-Glc-(1<->1')-Cer

Phenotype where environments contain beta-D-GalNAc-(1->4)-beta-D-GalNAc-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Man-(1->4)-beta-D-Glc-(1<->1')-Cer

Phenotype modified by environments containing beta-D-GalNAc-(1->4)-beta-D-GalNAc-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Man-(1->4)-beta-D-Glc-(1<->1')-Cer

Human Disease Model